The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B
Trial ID or NCT#
NCT02184442
Status
NOT RECRUITING
Purpose
The purpose of this study is to determine the safety and effectiveness of the SAPIEN XT™ THV with the associated delivery system for inoperable patients with severe symptomatic native aortic stenosis.
Official Title
The PARTNER II Trial "Placement of AoRTic TraNscathetER" Valves Trial" (US) [PII B] for Inoperable Patients
Eligibility Criteria
Ages Eligible for Study: Older than 19 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Investigator(s)
Rajesh Dash, MD PhD; Director of SSATHI & CardioClick
Cardiologist
Associate Professor of Medicine (Cardiovascular Medicine)
View on ClinicalTrials.gov
